instruction
stringlengths 26
882
| output
stringlengths 5
2.09k
| input
stringclasses 1
value |
|---|---|---|
What can you tell me about this molecule? COc1cc(C(=O)CO)cc(OC)c1O | The molecule is a flavoring agent, meaty, savory, and sulfur. | |
COc1cc(C(=O)CO)cc(OC)c1O What do you know about the molecule? | The molecule is a flavoring agent that is meaty and sulfur. The molecule is savory. | |
May I have a capsulized explanation for this molecule? COc1cc(C(=O)CO)cc(OC)c1O | The molecule is a flavoring agent, savory, sulfur, and meaty. | |
I need a brief explanation of the molecule denoted in this SMILES notation. COc1cc(C(=O)CO)cc(OC)c1O | The molecule is meaty, sulfur, and savory. The molecule is a flavoring agent. | |
COc1cc(C(=O)CO)cc(OC)c1O The above is a compound. Could you please tell me something about it? | The molecule is a flavoring agent that is savory and sulfur. The molecule is meaty. | |
What can you tell me about this molecule? CC1(C)COCN1C(=O)n1nnc2ncccc21 | The molecule is a faah inhibitor. | |
Describe this molecule: CC1(C)COCN1C(=O)n1nnc2ncccc21 | The molecule is a faah inhibitor. | |
Can you briefly describe the molecular encoded by this SMILES notation? CC1(C)COCN1C(=O)n1nnc2ncccc21 | The molecule is a faah inhibitor. | |
CC1(C)COCN1C(=O)n1nnc2ncccc21 The above is a compound. Could you please tell me something about it? | The molecule is a faah inhibitor. | |
CC1(C)COCN1C(=O)n1nnc2ncccc21 The above is a compound. Could you please tell me something about it? | The molecule is a faah inhibitor. | |
What can you tell me about this molecule? CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC | The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease and barth syndrome. | |
CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a apoptosis that impacts tangier disease, barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts diabetic heart disease. | |
CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a cholesterol translocation. The molecule is a apoptosis, a stabilizing cytochrome oxidase, and a stabilizing mitochondrial structure, and it impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation that impacts diabetic heart disease, non-alcoholic fatty liver disease, tangier disease, and aging. | |
Can you briefly describe the molecular encoded by this SMILES notation? CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC | The molecule is a cholesterol translocation. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation, impacting both barth syndrome and aging. The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease. | |
Please give me some details about this molecule. CCC=CCC=CCC=CCC=CCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC | The molecule is a cholesterol translocation, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and aging. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. | |
Tell me something about this molecule: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC | It impacts cardiovascular disease, atherosclerosis, and metabolic syndrome. The molecule is a nutrient and a fat storage, impacting both pancreatitis and thyroxine treatment. | |
Tell me something about this molecule: CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC | The molecule is a nutrient that impacts cardiovascular disease, pancreatitis, atherosclerosis, and metabolic syndrome. The molecule is a fat storage that impacts thyroxine treatment. | |
Could you give me a brief introduction to this molecule? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC | The molecule is a fat storage that impacts both atherosclerosis and pancreatitis. The molecule is a nutrient and thyroxine treatment, impacting both metabolic syndrome and cardiovascular disease. | |
Can you briefly describe the molecular encoded by this SMILES notation? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC | The molecule is a nutrient and is part of the thyroxine treatment class, affecting metabolic syndrome, atherosclerosis, cardiovascular disease, and pancreatitis. The molecule is a fat storage. | |
Please give me some details about this molecule. CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCC=CCC=CCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCCCC=CCCCCCCCC | The molecule is a fat storage and a nutrient, which impacts both pancreatitis and atherosclerosis, and is characterized as thyroxine treatment. It impacts both cardiovascular disease and metabolic syndrome. | |
CC(C)=CCCC(C)=CCn1cc(CN2CCCC2)c2cc(F)ccc21 The above is a compound. Could you please tell me something about it? | The molecule is a anti cancer. | |
Describe this molecule: CC(C)=CCCC(C)=CCn1cc(CN2CCCC2)c2cc(F)ccc21 | It belongs to the anti cancer class of molecules. | |
CC(C)=CCCC(C)=CCn1cc(CN2CCCC2)c2cc(F)ccc21 What do you know about the molecule? | The molecule is anti cancer. | |
CC(C)=CCCC(C)=CCn1cc(CN2CCCC2)c2cc(F)ccc21 What do you know about the molecule? | The molecule is anti cancer. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CC(C)=CCCC(C)=CCn1cc(CN2CCCC2)c2cc(F)ccc21 | It belongs to the anti cancer class of molecules. | |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC What do you know about the molecule? | The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, diabetic heart disease, and aging. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. | |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC What do you know about the molecule? | The molecule is a apoptosis. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation, impacting both barth syndrome and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, and tangier disease. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC | It impacts non-alcoholic fatty liver disease, aging, barth syndrome, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, a cholesterol translocation, and a stabilizing cytochrome oxidase, and it impacts tangier disease. The molecule is both a apoptosis and a proton trap for oxidative phosphorylation. | |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC What do you know about the molecule? | It impacts tangier disease. The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, and a apoptosis, and it impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, aging, and diabetic heart disease. | |
Can you briefly describe the molecular encoded by this SMILES notation? CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC=CCC=CCC=CCC=CCC=CCCCCC | The molecule is a stabilizing cytochrome oxidase that impacts both non-alcoholic fatty liver disease and aging. The molecule is a cholesterol translocation and stabilizing mitochondrial structure, and it impacts tangier disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both diabetic heart disease and barth syndrome. | |
Here is a molecule represented with SMILE: CC(=CC=CN)Cc1ccccn1 . Please describe it in natural language. | It impacts cancer treatment. | |
Please provide a brief introduction to this molecule. CC(=CC=CN)Cc1ccccn1 | It belongs to the cancer treatment class of molecules. | |
Tell me something about this molecule: CC(=CC=CN)Cc1ccccn1 | The molecule is cancer treatment. | |
What can you tell me about this molecule? CC(=CC=CN)Cc1ccccn1 | The molecule is cancer treatment. | |
Could you give me a brief introduction to this molecule? CC(=CC=CN)Cc1ccccn1 | It impacts cancer treatment. | |
I need a brief explanation of the molecule denoted in this SMILES notation. COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1 | The molecule is a hcv inhibitor and is anti viral. | |
Could you give me a brief introduction to this molecule? COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1 | The molecule is a hcv inhibitor and is anti viral. | |
Please provide a brief introduction to this molecule. COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1 | The molecule is both a hcv inhibitor and a anti viral. | |
Describe this molecule: COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1 | The molecule is a hcv inhibitor and belongs to the anti viral class of molecules. | |
I need a brief explanation of the molecule denoted in this SMILES notation. COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1 | The molecule is a hcv inhibitor and is anti viral. | |
What can you tell me about this molecule? C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C | Hazardous decomposition products formed under fire conditions: carbon oxides, silicon oxides. | |
Tell me something about this molecule: C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C | Hazardous decomposition products formed under fire conditions: carbon oxides, silicon oxides. | |
Can you briefly describe the molecular encoded by this SMILES notation? C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C | Hazardous decomposition products formed under fire conditions: carbon oxides, silicon oxides. | |
Here is a molecule represented with SMILE: C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C . Please describe it in natural language. | Hazardous decomposition products formed under fire conditions: carbon oxides, silicon oxides. | |
Here is a molecule represented with SMILE: C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C . Please describe it in natural language. | Hazardous decomposition products formed under fire conditions: carbon oxides, silicon oxides. | |
Here is a molecule represented with SMILE: CC(C)(C)CN1C(=O)C(CCC#N)OC(c2ccccc2Cl)c2cc(Cl)ccc21 . Please describe it in natural language. | The molecule is both a anti fungal and a hypercholesterolemia treatment. | |
Can you briefly describe the molecular encoded by this SMILES notation? CC(C)(C)CN1C(=O)C(CCC#N)OC(c2ccccc2Cl)c2cc(Cl)ccc21 | The molecule is a member of the anti fungal class and affects hypercholesterolemia treatment. | |
Here is a molecule represented with SMILE: CC(C)(C)CN1C(=O)C(CCC#N)OC(c2ccccc2Cl)c2cc(Cl)ccc21 . Please describe it in natural language. | The molecule is a anti fungal that impacts hypercholesterolemia treatment. | |
CC(C)(C)CN1C(=O)C(CCC#N)OC(c2ccccc2Cl)c2cc(Cl)ccc21 What do you know about the molecule? | The molecule is a anti fungal and is hypercholesterolemia treatment. | |
I'd like a short overview about this molecule. Can you do that? CC(C)(C)CN1C(=O)C(CCC#N)OC(c2ccccc2Cl)c2cc(Cl)ccc21 | The molecule is a hypercholesterolemia treatment and is anti fungal. | |
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC | The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, barth syndrome, and non-alcoholic fatty liver disease. | |
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC | The molecule is a proton trap for oxidative phosphorylation and a apoptosis, impacting both non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts diabetic heart disease and aging. It impacts barth syndrome. | |
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC | The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, a proton trap for oxidative phosphorylation, and a stabilizing cytochrome oxidase, and it impacts diabetic heart disease. | |
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a apoptosis and a proton trap for oxidative phosphorylation, impacting both tangier disease and barth syndrome. | |
CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OC(COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCC=CCC=CCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a cholesterol translocation that impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation. It impacts aging, non-alcoholic fatty liver disease, barth syndrome, and tangier disease. | |
May I have a capsulized explanation for this molecule? COc1c(OC(=O)c2ccccc2)c2cccc(OC(C)(C)C)c2oc1=O | The molecule is a anti allergic agent and belongs to the anti allergic class of molecules. | |
I'd like a short overview about this molecule. Can you do that? COc1c(OC(=O)c2ccccc2)c2cccc(OC(C)(C)C)c2oc1=O | The molecule is a anti allergic and belongs to the anti allergic agent class of molecules. | |
COc1c(OC(=O)c2ccccc2)c2cccc(OC(C)(C)C)c2oc1=O The above is a compound. Could you please tell me something about it? | The molecule is anti allergic and anti allergic agent. | |
Tell me something about this molecule: COc1c(OC(=O)c2ccccc2)c2cccc(OC(C)(C)C)c2oc1=O | The molecule is a anti allergic and is anti allergic agent. | |
COc1c(OC(=O)c2ccccc2)c2cccc(OC(C)(C)C)c2oc1=O The above is a compound. Could you please tell me something about it? | The molecule is a anti allergic member of the anti allergic agent class. | |
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC What do you know about the molecule? | It impacts thyroxine treatment. The molecule is a fat storage and a nutrient that impacts pancreatitis, atherosclerosis, cardiovascular disease, and metabolic syndrome. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC | The molecule is a nutrient and a fat storage, impacting both metabolic syndrome and pancreatitis. The molecule is a thyroxine treatment that impacts both cardiovascular disease and atherosclerosis. | |
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC | The molecule is a fat storage that impacts atherosclerosis. The molecule is a nutrient that belongs to the thyroxine treatment class of molecules, impacting pancreatitis, cardiovascular disease, and metabolic syndrome. | |
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a nutrient that impacts both atherosclerosis and cardiovascular disease. The molecule is a fat storage and thyroxine treatment, impacting both metabolic syndrome and pancreatitis. | |
CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCCCCCC=CCCCCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a nutrient, thyroxine treatment, fat storage that impacts cardiovascular disease, atherosclerosis, and metabolic syndrome. It impacts pancreatitis. | |
May I have a capsulized explanation for this molecule? CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1 | The molecule is anti bacterial. | |
CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1 What do you know about the molecule? | The molecule is anti bacterial. | |
Please give me some details about this molecule. CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1 | The molecule is a anti bacterial. | |
CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1 The above is a compound. Could you please tell me something about it? | It belongs to the anti bacterial class of molecules. | |
CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1 The above is a compound. Could you please tell me something about it? | The molecule is a anti bacterial. | |
I'd like a short overview about this molecule. Can you do that? CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, aging, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts barth syndrome and diabetic heart disease. | |
CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C The above is a compound. Could you please tell me something about it? | The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, aging, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts barth syndrome and non-alcoholic fatty liver disease. | |
Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C . Please describe it in natural language. | The molecule is a stabilizing mitochondrial structure, a stabilizing cytochrome oxidase, and a cholesterol translocation, and it impacts tangier disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. | |
Describe this molecule: CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and aging. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts tangier disease, barth syndrome, and diabetic heart disease. The molecule is a cholesterol translocation. | |
Please provide a brief introduction to this molecule. CCCCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C | The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a apoptosis that impacts aging, barth syndrome, and diabetic heart disease. | |
Describe this molecule: CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC | The molecule is a fat storage that impacts both cardiovascular disease and atherosclerosis. The molecule is a nutrient that impacts metabolic syndrome, thyroxine treatment, and pancreatitis. | |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC What do you know about the molecule? | The molecule is a nutrient that impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and belongs to the thyroxine treatment class of molecules, impacting both metabolic syndrome and atherosclerosis. | |
I'd like a short overview about this molecule. Can you do that? CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC | It impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and a nutrient that impacts cardiovascular disease, pancreatitis, and thyroxine treatment. | |
Tell me something about this molecule: CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC | The molecule is a fat storage that impacts both cardiovascular disease and atherosclerosis. The molecule is a nutrient and a thyroxine treatment, impacting both pancreatitis and metabolic syndrome. | |
CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC(COC(=O)CCCC=CCC=CCC=CCC=CCC=CCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC What do you know about the molecule? | The molecule is a nutrient that impacts both pancreatitis and atherosclerosis. The molecule is a fat storage and belongs to the thyroxine treatment class of molecules, impacting both cardiovascular disease and metabolic syndrome. | |
CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C What do you know about the molecule? | It impacts obesity. The molecule is a energy storage, energy source, membrane stabilizer, inflammatory that impacts pancreatitis and atherosclerosis. The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome, cancer, and cardiovascular disease. | |
Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | The molecule is a nutrient that impacts both metabolic syndrome and obesity. The molecule is a fat storage and a inflammatory, impacting both cardiovascular disease and atherosclerosis. The molecule is a membrane stabilizer, a energy source, and a energy storage that impacts both cancer and pancreatitis, and is thyroxine treatment. | |
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | The molecule is a fat storage, energy storage, membrane stabilizer that impacts cancer, obesity, and pancreatitis. The molecule is a inflammatory, a nutrient, and a energy source that impacts both cardiovascular disease and metabolic syndrome, and is thyroxine treatment. It impacts atherosclerosis. | |
Here is a molecule represented with SMILE: CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C . Please describe it in natural language. | The molecule is a inflammatory that impacts pancreatitis. The molecule is a energy source, fat storage, energy storage, thyroxine treatment that impacts atherosclerosis. The molecule is a membrane stabilizer and a nutrient that impacts cancer, obesity, metabolic syndrome, and cardiovascular disease. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | The molecule is a membrane stabilizer, energy storage, inflammatory that impacts cancer and cardiovascular disease. The molecule is a nutrient, energy source, fat storage that impacts obesity, thyroxine treatment, and metabolic syndrome. It impacts both pancreatitis and atherosclerosis. | |
Could you give me a brief introduction to this molecule? CCC=CCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, non-alcoholic fatty liver disease, and tangier disease. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCC=CCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts non-alcoholic fatty liver disease, tangier disease, and aging. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts diabetic heart disease and barth syndrome. | |
CCC=CCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC The above is a compound. Could you please tell me something about it? | The molecule is a stabilizing mitochondrial structure that impacts both tangier disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts both aging and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, a apoptosis, and a cholesterol translocation, and it impacts diabetic heart disease. | |
May I have a capsulized explanation for this molecule? CCC=CCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a apoptosis that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase, impacting both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation, impacting both barth syndrome and tangier disease. | |
What can you tell me about this molecule? CCC=CCC=CCC=CCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging. The molecule is a stabilizing mitochondrial structure, apoptosis, cholesterol translocation that impacts barth syndrome and tangier disease. | |
CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCC(O)CC)COP(=O)([O-])OCC[N+](C)(C)C What do you know about the molecule? | The molecule is a nutrient that impacts atherosclerosis, breast cancer, ulcerative colitis, and cervical cancer. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCC(O)CC)COP(=O)([O-])OCC[N+](C)(C)C | The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. | |
Could you give me a brief introduction to this molecule? CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCC(O)CC)COP(=O)([O-])OCC[N+](C)(C)C | The molecule is a nutrient that affects breast cancer by impacting atherosclerosis, ulcerative colitis, and cervical cancer. | |
Can you briefly describe the molecular encoded by this SMILES notation? CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCC(O)CC)COP(=O)([O-])OCC[N+](C)(C)C | The molecule is a nutrient that impacts both breast cancer and atherosclerosis. It influences cervical cancer and ulcerative colitis. | |
I need a brief explanation of the molecule denoted in this SMILES notation. CCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCC=CCC=CCC=CCC=CCCC(O)CC)COP(=O)([O-])OCC[N+](C)(C)C | The molecule is a nutrient that impacts atherosclerosis, ulcerative colitis, breast cancer, and cervical cancer. | |
Tell me something about this molecule: CCC(C)CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a emulsifier, proton trap for oxidative phosphorylation, surfactant, energy storage that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy source and smooth, and it impacts barth syndrome. The molecule is a stabilizing mitochondrial structure, a membrane stabilizer, and a cholesterol translocation, and it impacts aging. The molecule is a nutritional supplement, apoptosis, stabilizing cytochrome oxidase, food additive that impacts tangier disease. | |
Describe this molecule: CCC(C)CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a food additive and apoptosis, and it impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase, a emulsifier, and a surfactant, and it impacts aging. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a energy storage and a nutritional supplement, it impacts tangier disease, and is smooth. The molecule is a energy source, a cholesterol translocation, and a membrane stabilizer. | |
CCC(C)CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C What do you know about the molecule? | The molecule is a membrane stabilizer, food additive, surfactant, nutritional supplement, stabilizing cytochrome oxidase that impacts tangier disease. The molecule is a emulsifier, energy source, cholesterol translocation, and apoptosis, impacts aging, and is smooth. The molecule is a energy storage, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. | |
Here is a molecule represented with SMILE: CCC(C)CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C . Please describe it in natural language. | The molecule is a surfactant, a proton trap for oxidative phosphorylation, and a nutritional supplement. The molecule is a energy source, a cholesterol translocation, and a membrane stabilizer, and it impacts tangier disease. The molecule is a stabilizing mitochondrial structure and a emulsifier, impacting both diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a energy storage and a apoptosis, it impacts barth syndrome, and is smooth. The molecule is a food additive and stabilizing cytochrome oxidase, and it impacts aging. | |
Tell me something about this molecule: CCC(C)CCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | The molecule is a emulsifier and smooth, impacting both aging and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, a energy storage, and a stabilizing cytochrome oxidase. The molecule is a apoptosis, a cholesterol translocation, and a nutritional supplement, and it impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and membrane stabilizer, and it impacts barth syndrome. The molecule is a energy source, a food additive, and a surfactant, and it impacts tangier disease. |
Subsets and Splits